← Eichor
Study identifier: NCT06634199 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Condition: Non-small Cell Lung Cancer Stage III · PDL1 Gene Mutation  ·  Sponsor: Fundación GECP

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Observational, multicenter, one-arm, non-comparative study. Data will be recorded in a retrospectively manner. The study will be based on secondary data collected from patient clinical chart completed by the doctor during routine visits. The primary objective is describe the antitumor immune response generated in the context of IO (immunotherapy) treatment after cCRT in patients with unresectable NSCLC treated in real world.

This description comes directly from the study's public registry record.

Talk to the study team

Eva Pereira  ·  +34934302006  ·  gecp@gecp.org

Always discuss trial participation with your own doctor first.

Locations (22)

Complejo Hospitalario Universitario Del FerrolFerrol, A Coruña, SpainRecruiting
Hospital General Universitario de AlicanteAlicante, Alicante, SpainRecruiting
ICO Badalona, Hospital Germans Trias i PujolBadalona, Barcelona, SpainRecruiting
Hospital Universitari Vall d' HebronBarcelona, Barcelona, SpainRecruiting
Hospital de la Santa Creu i Sant PauBarcelona, Barcelona, SpainRecruiting
Hospital De BasurtoBilbao, Bilbao, SpainRecruiting
Hospital General Universitario de Ciudad RealCiudad Real, Ciudad Real, SpainRecruiting
ICO Girona, Hospital Josep TruetaGirona, Girona, SpainRecruiting
Hospitalario Universitario A CoruñaA Coruña, La Coruña, SpainRecruiting
Hospital Universitari de Gran Canària Doctor NegrínLas Palmas de Gran Canaria, Las Palmas, SpainRecruiting
Hospital Universitario Lucus AugustiLugo, Lugo, SpainRecruiting
Hospital Universitario De La PrincesaMadrid, Madrid, SpainRecruiting

+ 10 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06634199